Power brands continue to grow ahead of industry growth The domestic pharma market (~| 1.3 trillion AIOCD MAT July 2019) is growing at 9-10% YoY. Branded generics dominate the pharmaceuticals market, constituting nearly 80% of market share in terms of revenue. Abbott India's top five brands have together registered a revenue CAGR of ~20%, leading combined contribution to Abbott India's sales to grow from 26% in March 2015 to nearly 34% in March 2019. Thus, it is evident that revenue growth has been driven by top brands (power brands) despite one of its top...